scispace - formally typeset
Search or ask a question

Showing papers by "University of Hamburg published in 2021"


Journal ArticleDOI
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Abstract: In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field.

1,129 citations


Journal ArticleDOI
TL;DR: In this article, a B-cell maturation antigen-directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expecable clinical outcomes with the use of idecabtagene vicleucel (ide-cel), also called bb2121.
Abstract: Background Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expec...

776 citations


Journal ArticleDOI
Dominik Pfister1, Dominik Pfister2, Nicolás Gonzalo Núñez3, Roser Pinyol4, Olivier Govaere5, Matthias Pinter6, Marta Szydlowska2, Revant Gupta7, Mengjie Qiu8, Aleksandra Deczkowska9, Assaf Weiner9, Florian Müller2, Ankit Sinha10, Ankit Sinha11, Ekaterina Friebel3, Thomas Engleitner10, Thomas Engleitner2, Daniela Lenggenhager3, Anja Moncsek3, Danijela Heide2, Kristin Stirm2, Jan Kosla2, Eleni Kotsiliti2, Valentina Leone2, Michael Dudek10, Suhail Yousuf8, Donato Inverso2, Donato Inverso12, Indrabahadur Singh2, Ana Teijeiro, Florian Castet4, Carla Montironi4, Philipp K. Haber13, Dina Tiniakos14, Dina Tiniakos5, Pierre Bedossa5, Simon Cockell5, Ramy Younes5, Ramy Younes15, Michele Vacca16, Fabio Marra17, Jörn M. Schattenberg, Michael Allison16, Elisabetta Bugianesi15, Vlad Ratziu18, Tiziana Pressiani, Antonio D'Alessio, Nicola Personeni19, Lorenza Rimassa19, Ann K. Daly5, Bernhard Scheiner6, Katharina Pomej6, Martha M. Kirstein20, Arndt Vogel20, Markus Peck-Radosavljevic, F. Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze21, Henning Wege21, Sandra Koch22, Arndt Weinmann22, Marco Bueter3, Fabian Rössler3, Alexander Siebenhüner3, Sara De Dosso, Jan-Philipp Mallm2, Viktor Umansky2, Viktor Umansky12, Manfred Jugold2, Tom Luedde23, Andrea Schietinger24, Andrea Schietinger25, Peter Schirmacher8, Brinda Emu2, Hellmut G. Augustin2, Hellmut G. Augustin12, Adrian T. Billeter8, Beat P. Müller-Stich8, Hiroto Kikuchi26, Dan G. Duda26, Fabian Kütting27, Dirk Waldschmidt27, Matthias P. Ebert12, Nuh N. Rahbari12, Henrik E. Mei28, Axel Schulz28, Marc Ringelhan10, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta13, Amaia Lujambio13, Jean-François Dufour29, Thomas U. Marron30, Thomas U. Marron13, Ahmed Kaseb31, Masatoshi Kudo32, Yi Hsiang Huang33, Yi Hsiang Huang34, Nabil Djouder, Katharina Wolter7, Lars Zender7, Lars Zender2, Parice N. Marche35, Parice N. Marche36, Thomas Decaens36, Thomas Decaens35, David J. Pinato37, Roland Rad2, Roland Rad10, Joachim C. Mertens3, Achim Weber3, Kristian Unger, Felix Meissner11, Susanne Roth8, Zuzana Macek Jilkova35, Zuzana Macek Jilkova37, Zuzana Macek Jilkova36, Manfred Claassen7, Quentin M. Anstee5, Ido Amit9, Percy A. Knolle10, Burkhard Becher3, Josep M. Llovet13, Josep M. Llovet4, Josep M. Llovet38, Mathias Heikenwalder2 
15 Apr 2021-Nature
TL;DR: The progressive accumulation of exhausted, unconventionally activated CD8+PD1+ T cells in NASH-affected livers provides a rationale for stratification of patients with HCC according to underlying aetiology in studies of immunotherapy as a primary or adjuvant treatment.
Abstract: Hepatocellular carcinoma (HCC) can have viral or non-viral causes1-5. Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treating HCC, but biomarker-based stratification of patients for optimal response to therapy is an unmet need6,7. Here we report the progressive accumulation of exhausted, unconventionally activated CD8+PD1+ T cells in NASH-affected livers. In preclinical models of NASH-induced HCC, therapeutic immunotherapy targeted at programmed death-1 (PD1) expanded activated CD8+PD1+ T cells within tumours but did not lead to tumour regression, which indicates that tumour immune surveillance was impaired. When given prophylactically, anti-PD1 treatment led to an increase in the incidence of NASH-HCC and in the number and size of tumour nodules, which correlated with increased hepatic CD8+PD1+CXCR6+, TOX+, and TNF+ T cells. The increase in HCC triggered by anti-PD1 treatment was prevented by depletion of CD8+ T cells or TNF neutralization, suggesting that CD8+ T cells help to induce NASH-HCC, rather than invigorating or executing immune surveillance. We found similar phenotypic and functional profiles in hepatic CD8+PD1+ T cells from humans with NAFLD or NASH. A meta-analysis of three randomized phase III clinical trials that tested inhibitors of PDL1 (programmed death-ligand 1) or PD1 in more than 1,600 patients with advanced HCC revealed that immune therapy did not improve survival in patients with non-viral HCC. In two additional cohorts, patients with NASH-driven HCC who received anti-PD1 or anti-PDL1 treatment showed reduced overall survival compared to patients with other aetiologies. Collectively, these data show that non-viral HCC, and particularly NASH-HCC, might be less responsive to immunotherapy, probably owing to NASH-related aberrant T cell activation causing tissue damage that leads to impaired immune surveillance. Our data provide a rationale for stratification of patients with HCC according to underlying aetiology in studies of immunotherapy as a primary or adjuvant treatment.

526 citations


Journal ArticleDOI
Richard J. Abbott1, T. D. Abbott2, Sheelu Abraham3, Fausto Acernese4  +1428 moreInstitutions (155)
TL;DR: In this article, the population of 47 compact binary mergers detected with a false-alarm rate of 0.614 were dynamically assembled, and the authors found that the BBH rate likely increases with redshift, but not faster than the star formation rate.
Abstract: We report on the population of 47 compact binary mergers detected with a false-alarm rate of 0.01 are dynamically assembled. Third, we estimate merger rates, finding RBBH = 23.9-+8.614.3 Gpc-3 yr-1 for BBHs and RBNS = 320-+240490 Gpc-3 yr-1 for binary neutron stars. We find that the BBH rate likely increases with redshift (85% credibility) but not faster than the star formation rate (86% credibility). Additionally, we examine recent exceptional events in the context of our population models, finding that the asymmetric masses of GW190412 and the high component masses of GW190521 are consistent with our models, but the low secondary mass of GW190814 makes it an outlier.

468 citations


Journal ArticleDOI
TL;DR: In this article, the authors investigated the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) and mental health of children and adolescents in Germany from the perspective of children themselves.
Abstract: The COVID-19 pandemic has caused unprecedented changes in the lives of 1.6 billion children and adolescents. First non-representative studies from China, India, Brazil, the US, Spain, Italy, and Germany pointed to a negative mental health impact. The current study is the first nationwide representative study to investigate the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) and mental health of children and adolescents in Germany from the perspective of children themselves. A representative online survey was conducted among n = 1586 families with 7- to 17-year-old children and adolescents between May 26 and June 10. The survey included internationally established and validated instruments for measuring HRQoL (KIDSCREEN-10), mental health problems (SDQ), anxiety (SCARED), and depression (CES-DC). Results were compared with data from the nationwide, longitudinal, representative BELLA cohort study (n = 1556) conducted in Germany before the pandemic. Two-thirds of the children and adolescents reported being highly burdened by the COVID-19 pandemic. They experienced significantly lower HRQoL (40.2% vs. 15.3%), more mental health problems (17.8% vs. 9.9%) and higher anxiety levels (24.1% vs. 14.9%) than before the pandemic. Children with low socioeconomic status, migration background and limited living space were affected significantly more. Health promotion and prevention strategies need to be implemented to maintain children's and adolescents' mental health, improve their HRQoL, and mitigate the burden caused by COVID-19, particularly for children who are most at risk.

436 citations


Journal ArticleDOI
Richard J. Abbott1, T. D. Abbott2, Sheelu Abraham3, Fausto Acernese4  +1692 moreInstitutions (195)
TL;DR: In this article, the authors reported the observation of gravitational waves from two compact binary coalescences in LIGO's and Virgo's third observing run with properties consistent with neutron star-black hole (NSBH) binaries.
Abstract: We report the observation of gravitational waves from two compact binary coalescences in LIGO’s and Virgo’s third observing run with properties consistent with neutron star–black hole (NSBH) binaries. The two events are named GW200105_162426 and GW200115_042309, abbreviated as GW200105 and GW200115; the first was observed by LIGO Livingston and Virgo and the second by all three LIGO–Virgo detectors. The source of GW200105 has component masses 8.9−1.5+1.2 and 1.9−0.2+0.3M⊙ , whereas the source of GW200115 has component masses 5.7−2.1+1.8 and 1.5−0.3+0.7M⊙ (all measurements quoted at the 90% credible level). The probability that the secondary’s mass is below the maximal mass of a neutron star is 89%–96% and 87%–98%, respectively, for GW200105 and GW200115, with the ranges arising from different astrophysical assumptions. The source luminosity distances are 280−110+110 and 300−100+150Mpc , respectively. The magnitude of the primary spin of GW200105 is less than 0.23 at the 90% credible level, and its orientation is unconstrained. For GW200115, the primary spin has a negative spin projection onto the orbital angular momentum at 88% probability. We are unable to constrain the spin or tidal deformation of the secondary component for either event. We infer an NSBH merger rate density of 45−33+75Gpc−3yr−1 when assuming that GW200105 and GW200115 are representative of the NSBH population or 130−69+112Gpc−3yr−1 under the assumption of a broader distribution of component masses.

374 citations


Journal ArticleDOI
01 Jul 2021-Nature
TL;DR: This work uses programmable arrays of individual atoms trapped in optical tweezers, with interactions controlled by laser excitation to Rydberg states, to implement an iconic many-body problem-the antiferromagnetic two-dimensional transverse-field Ising model, and demonstrates that this platform can be readily used to address open questions in many- body physics.
Abstract: Quantum simulation using synthetic systems is a promising route to solve outstanding quantum many-body problems in regimes where other approaches, including numerical ones, fail1. Many platforms are being developed towards this goal, in particular based on trapped ions2–4, superconducting circuits5–7, neutral atoms8–11 or molecules12,13. All of these platforms face two key challenges: scaling up the ensemble size while retaining high-quality control over the parameters, and validating the outputs for these large systems. Here we use programmable arrays of individual atoms trapped in optical tweezers, with interactions controlled by laser excitation to Rydberg states11, to implement an iconic many-body problem—the antiferromagnetic two-dimensional transverse-field Ising model. We push this platform to a regime with up to 196 atoms manipulated with high fidelity and probe the antiferromagnetic order by dynamically tuning the parameters of the Hamiltonian. We illustrate the versatility of our platform by exploring various system sizes on two qualitatively different geometries—square and triangular arrays. We obtain good agreement with numerical calculations up to a computationally feasible size (approximately 100 particles). This work demonstrates that our platform can be readily used to address open questions in many-body physics. Programmable quantum simulation of two-dimensional antiferromagnets is achieved with up to 196 neutral atoms, and the capability of the platform is demonstrated on square and triangular arrays.

348 citations


Journal ArticleDOI
Peter Predehl1, Robert Andritschke1, V. Arefiev, V. Babyshkin, O. Batanov, Werner Becker1, Hans Böhringer1, A. V. Bogomolov, Th. Boller1, Katharina Borm2, Katharina Borm3, W. Bornemann1, Heinrich Bräuninger1, Marcus Brüggen4, Hermann Brunner1, Marcella Brusa5, Marcella Brusa6, Esra Bulbul1, M. Buntov, Vadim Burwitz1, Wolfgang Burkert1, N. Clerc7, E. Churazov1, D. Coutinho1, Thomas Dauser8, Konrad Dennerl1, Victor Doroshenko9, Josef Eder1, Valentin Emberger1, Tanja Eraerds1, Alexis Finoguenov1, Michael Freyberg1, Peter Friedrich1, S. Friedrich1, Maria Fürmetz1, Antonis Georgakakis, Marat Gilfanov1, S. Granato1, Christoph Grossberger1, A. Gueguen1, P. Gureev, Frank Haberl1, O. Hälker1, Gisela Hartner1, Guenther Hasinger, H. Huber1, Long Ji9, Andreas von Kienlin1, W. Kink1, F. Korotkov, Ingo Kreykenbohm8, Georg Lamer10, I. Lomakin, I. Lapshov, Tie Liu1, Chandreyee Maitra1, Norbert Meidinger1, B. Menz1, Andrea Merloni1, T. Mernik2, Benjamin Mican1, Joseph J. Mohr11, Sebastian Müller1, Kirpal Nandra1, V. Nazarov, Florian Pacaud3, M. N. Pavlinsky, Emanuele Perinati9, Elmar Pfeffermann1, Daniel Pietschner1, Miriam E. Ramos-Ceja1, Arne Rau1, Jonas Reiffers1, Thomas H. Reiprich3, Jan Robrade4, Mara Salvato1, Jeremy S. Sanders1, Andrea Santangelo9, Manami Sasaki8, H. Scheuerle2, Christian Schmid8, Jürgen H. M. M. Schmitt4, Axel Schwope10, A. Shirshakov, Matthias Steinmetz10, Ian M. Stewart1, Lothar Strüder1, Rashid Sunyaev1, C. Tenzer9, Lars Tiedemann1, Joachim Trümper1, V. Voron, P. Weber8, Joern Wilms8, Valeri Yaroshenko1 
Abstract: eROSITA (extended ROentgen Survey with an Imaging Telescope Array) is the primary instrument on the Spectrum-Roentgen-Gamma (SRG) mission, which was successfully launched on July 13, 2019, from the Baikonour cosmodrome. After the commissioning of the instrument and a subsequent calibration and performance verification phase, eROSITA started a survey of the entire sky on December 13, 2019. By the end of 2023, eight complete scans of the celestial sphere will have been performed, each lasting six months. At the end of this program, the eROSITA all-sky survey in the soft X-ray band (0.2–2.3 keV) will be about 25 times more sensitive than the ROSAT All-Sky Survey, while in the hard band (2.3–8 keV) it will provide the first ever true imaging survey of the sky. The eROSITA design driving science is the detection of large samples of galaxy clusters up to redshifts z > 1 in order to study the large-scale structure of the universe and test cosmological models including Dark Energy. In addition, eROSITA is expected to yield a sample of a few million AGNs, including obscured objects, revolutionizing our view of the evolution of supermassive black holes. The survey will also provide new insights into a wide range of astrophysical phenomena, including X-ray binaries, active stars, and diffuse emission within the Galaxy. Results from early observations, some of which are presented here, confirm that the performance of the instrument is able to fulfil its scientific promise. With this paper, we aim to give a concise description of the instrument, its performance as measured on ground, its operation in space, and also the first results from in-orbit measurements.

338 citations


Journal ArticleDOI
Richard J. Abbott1, T. D. Abbott2, Sheelu Abraham3, Fausto Acernese4  +1335 moreInstitutions (144)
TL;DR: The data recorded by these instruments during their first and second observing runs are described, including the gravitational-wave strain arrays, released as time series sampled at 16384 Hz.

320 citations


Journal ArticleDOI
14 Jan 2021-Nature
TL;DR: Using single-cell RNA sequencing, the transcriptomes of cells from the proximal and non-proximal tubules of healthy and fibrotic human kidneys are profiled to map the entire human kidney and identify distinct subpopulations of pericytes and fibroblasts as the main cellular sources of scar-forming myofibro Blasts during human kidney fibrosis.
Abstract: Kidney fibrosis is the hallmark of chronic kidney disease progression; however, at present no antifibrotic therapies exist1-3. The origin, functional heterogeneity and regulation of scar-forming cells that occur during human kidney fibrosis remain poorly understood1,2,4. Here, using single-cell RNA sequencing, we profiled the transcriptomes of cells from the proximal and non-proximal tubules of healthy and fibrotic human kidneys to map the entire human kidney. This analysis enabled us to map all matrix-producing cells at high resolution, and to identify distinct subpopulations of pericytes and fibroblasts as the main cellular sources of scar-forming myofibroblasts during human kidney fibrosis. We used genetic fate-tracing, time-course single-cell RNA sequencing and ATAC-seq (assay for transposase-accessible chromatin using sequencing) experiments in mice, and spatial transcriptomics in human kidney fibrosis, to shed light on the cellular origins and differentiation of human kidney myofibroblasts and their precursors at high resolution. Finally, we used this strategy to detect potential therapeutic targets, and identified NKD2 as a myofibroblast-specific target in human kidney fibrosis.

301 citations


Journal ArticleDOI
Eirini Karyotaki1, Eirini Karyotaki2, Eirini Karyotaki3, Orestis Efthimiou3, Orestis Efthimiou4, Clara Miguel1, Clara Miguel5, Frederic Maas genannt Bermpohl6, Toshi A. Furukawa7, Toshi A. Furukawa6, Pim Cuijpers5, Pim Cuijpers1, Heleen Riper1, Heleen Riper5, Vikram Patel2, Adriana Mira, Alan W Gemmil, Albert Yeung2, Alfred Lange8, Alishia D. Williams9, Andrew Mackinnon10, Andrew Mackinnon9, Anna C. M. Geraedts, Annemieke van Straten1, Annemieke van Straten5, Björn Meyer11, Cecilia Björkelund12, Christine Knaevelsrud13, Christopher G. Beevers14, Cristina Botella15, Cristina Botella16, Daniel R. Strunk17, David C. Mohr18, David Daniel Ebert19, David Kessler20, David Kessler21, Derek Richards22, Elizabeth Littlewood23, Erik Forsell24, Fan Feng2, Fang Wang25, Gerhard Andersson26, Gerhard Andersson24, Heather D. Hadjistavropoulos27, Heleen Christensen9, Iony D. Ezawa17, Isabella Choi28, Isabelle M. Rosso2, Isabelle M. Rosso29, Jan Philipp Klein30, Jason Shumake14, Javier García-Campayo31, Jeannette Milgrom, Jessica Smith32, Jesus Montero-Marin4, Jill M. Newby9, Juana Bretón-López15, Juana Bretón-López16, Justine Schneider33, Kristofer Vernmark26, Lara Bücker34, Lisa Sheeber35, Lisanne Warmerdam, Louise Farrer36, Manuel Heinrich13, Marcus J.H. Huibers5, Marcus J.H. Huibers1, Marie Kivi12, Martin Kraepelien24, Nicholas R. Forand37, Nicholas R. Forand38, Nicky Pugh27, Nils Lindefors24, Ove Lintvedt, Pavle Zagorscak13, Per Carlbring39, Rachel Phillips32, Robert Johansson39, Ronald C. Kessler2, Sally Brabyn, Sarah Perini, Scott L. Rauch29, Simon Gilbody40, Simon Gilbody23, Steffen Moritz34, Thomas Berger3, Victor J M Pop41, Viktor Kaldo42, Viktor Kaldo24, Viola Spek41, Yvonne Forsell24 
TL;DR: In this article, the authors conducted a systematic review and IPD network meta-analysis and estimated relative treatment effect sizes across different patient characteristics through IPD-network meta-regression, and found that both guided and unguided iCBT were associated with more effectiveness as measured by PHQ-9 scores than control treatments over the short term and the long term.
Abstract: Importance Personalized treatment choices would increase the effectiveness of internet-based cognitive behavioral therapy (iCBT) for depression to the extent that patients differ in interventions that better suit them. Objective To provide personalized estimates of short-term and long-term relative efficacy of guided and unguided iCBT for depression using patient-level information. Data Sources We searched PubMed, Embase, PsycInfo, and Cochrane Library to identify randomized clinical trials (RCTs) published up to January 1, 2019. Study Selection Eligible RCTs were those comparing guided or unguided iCBT against each other or against any control intervention in individuals with depression. Available individual patient data (IPD) was collected from all eligible studies. Depression symptom severity was assessed after treatment, 6 months, and 12 months after randomization. Data Extraction and Synthesis We conducted a systematic review and IPD network meta-analysis and estimated relative treatment effect sizes across different patient characteristics through IPD network meta-regression. Main Outcomes and Measures Patient Health Questionnaire–9 (PHQ-9) scores. Results Of 42 eligible RCTs, 39 studies comprising 9751 participants with depression contributed IPD to the IPD network meta-analysis, of which 8107 IPD were synthesized. Overall, both guided and unguided iCBT were associated with more effectiveness as measured by PHQ-9 scores than control treatments over the short term and the long term. Guided iCBT was associated with more effectiveness than unguided iCBT (mean difference [MD] in posttreatment PHQ-9 scores, −0.8; 95% CI, −1.4 to −0.2), but we found no evidence of a difference at 6 or 12 months following randomization. Baseline depression was found to be the most important modifier of the relative association for efficacy of guided vs unguided iCBT. Differences between unguided and guided iCBT in people with baseline symptoms of subthreshold depression (PHQ-9 scores 5-9) were small, while guided iCBT was associated with overall better outcomes in patients with baseline PHQ-9 greater than 9. Conclusions and Relevance In this network meta-analysis with IPD, guided iCBT was associated with more effectiveness than unguided iCBT for individuals with depression, benefits were more substantial in individuals with moderate to severe depression. Unguided iCBT was associated with similar effectiveness among individuals with symptoms of mild/subthreshold depression. Personalized treatment selection is entirely possible and necessary to ensure the best allocation of treatment resources for depression.

Journal ArticleDOI
TL;DR: The Concise Guide to PHARMACOLOGY 2021/22 as mentioned in this paper provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands.
Abstract: The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15538. G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Journal ArticleDOI
TL;DR: A conceptual framework of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) assays is proposed in this paper, which point out current challenges of CTC and ctDNA research.
Abstract: Over the past 10 years, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) have received enormous attention as new biomarkers and subjects of translational research. Although both biomarkers are already used in numerous clinical trials, their clinical utility is still under investigation with promising first results. Clinical applications include early cancer detection, improved cancer staging, early detection of relapse, real-time monitoring of therapeutic efficacy, and detection of therapeutic targets and resistance mechanisms. Here, we propose a conceptual framework of CTC and ctDNA assays and point out current challenges of CTC and ctDNA research, which might structure this dynamic field of translational cancer research. SIGNIFICANCE: The analysis of blood for CTCs or cell-free nucleic acids called "liquid biopsy" has opened new avenues for cancer diagnostics, including early detection of tumors, improved risk assessment and staging, as well as early detection of relapse and monitoring of tumor evolution in the context of cancer therapies.


Journal ArticleDOI
TL;DR: It is found that below-ground traits with widest importance in plant and ecosystem functioning are not those most commonly measured, and advocate that establishing causal hierarchical links among root traits will provide a hypothesis-based framework to identify the most parsimonious sets of traits with strongest influence on the functions, and to link genotypes to plant andcosystem functioning.
Abstract: The effects of plants on the biosphere, atmosphere and geosphere are key determinants of terrestrial ecosystem functioning. However, despite substantial progress made regarding plant belowground components, we are still only beginning to explore the complex relationships between root traits and functions. Drawing on the literature in plant physiology, ecophysiology, ecology, agronomy and soil science, we reviewed 24 aspects of plant and ecosystem functioning and their relationships with a number of root system traits, including aspects of architecture, physiology, morphology, anatomy, chemistry, biomechanics and biotic interactions. Based on this assessment, we critically evaluated the current strengths and gaps in our knowledge, and identify future research challenges in the field of root ecology. Most importantly, we found that belowground traits with the broadest importance in plant and ecosystem functioning are not those most commonly measured. Also, the estimation of trait relative importance for functioning requires us to consider a more comprehensive range of functionally relevant traits from a diverse range of species, across environments and over time series. We also advocate that establishing causal hierarchical links among root traits will provide a hypothesis-based framework to identify the most parsimonious sets of traits with the strongest links on functions, and to link genotypes to plant and ecosystem functioning.

Journal ArticleDOI
David V. Conti1, Burcu F. Darst1, Lilit C. Moss1, Edward J. Saunders2  +251 moreInstitutions (100)
TL;DR: This paper conducted a meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants.
Abstract: Prostate cancer is a highly heritable disease with large disparities in incidence rates across ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants. The top genetic risk score (GRS) decile was associated with odds ratios that ranged from 5.06 (95% confidence interval (CI), 4.84–5.29) for men of European ancestry to 3.74 (95% CI, 3.36–4.17) for men of African ancestry. Men of African ancestry were estimated to have a mean GRS that was 2.18-times higher (95% CI, 2.14–2.22), and men of East Asian ancestry 0.73-times lower (95% CI, 0.71–0.76), than men of European ancestry. These findings support the role of germline variation contributing to population differences in prostate cancer risk, with the GRS offering an approach for personalized risk prediction.

Journal ArticleDOI
TL;DR: Cell-free DNA derived from tumours is present in the plasma of cancer patients and can be used to analyse different features of DNA, such as methylation status, size fragment patterns, transcriptomics and viral load, which open new avenues for the analysis of liquid biopsy samples from cancer patients.
Abstract: Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal with the detection of mutations. The analysis of cfDNA is often discussed in the context of the noninvasive detection of mutations that lead to resistance mechanisms and therapeutic and disease monitoring in cancer patients. Indeed, substantial advances have been made in this area, with the development of methods that reach high sensitivity and can interrogate a large number of genes. Interestingly, however, cfDNA can also be used to analyse different features of DNA, such as methylation status, size fragment patterns, transcriptomics and viral load, which open new avenues for the analysis of liquid biopsy samples from cancer patients. This review will focus on the new perspectives and challenges of cfDNA analysis from mutation detection in patients with solid malignancies.

Journal ArticleDOI
TL;DR: In this paper, the authors present a range of its outcomes by synthesizing results from the participating global coupled Earth system models for concentration driven simulations, focusing mainly on the analysis of strictly geophysical outcomes: mainly global averages and spatial patterns of change for surface air temperature and precipitation.
Abstract: . The Scenario Model Intercomparison Project (ScenarioMIP) defines and coordinates the primary future climate projections within the Coupled Model Intercomparison Project Phase 6 (CMIP6). This paper presents a range of its outcomes by synthesizing results from the participating global coupled Earth system models for concentration driven simulations. We limit our scope to the analysis of strictly geophysical outcomes: mainly global averages and spatial patterns of change for surface air temperature and precipitation. We also compare CMIP6 projections to CMIP5 results, especially for those scenarios that were designed to provide continuity across the CMIP phases, at the same time highlighting important differences in forcing composition, as well as in results. The range of future temperature and precipitation changes by the end of the century encompassing the Tier 1 experiments (SSP1-2.6, SSP2-4.5, SSP3-7.0 and SSP5-8.5) and SSP1-1.9 spans a larger range of outcomes compared to CMIP5, due to higher warming (by 1.15 °C) reached at the upper end of the 5–95 % envelope of the highest scenario, SSP5-8.5. This is due to both the wider range of radiative forcing that the new scenarios cover and to higher climate sensitivities in some of the new models compared to their CMIP5 predecessors. Spatial patterns of change for temperature and precipitation averaged over models and scenarios have familiar features, and an analysis of their variations confirms model structural differences to be the dominant source of uncertainty. Models also differ with respect to the size and evolution of internal variability as measured by individual models' initial condition ensembles' spread, according to a set of initial condition ensemble simulations available under SSP3-7.0. The same experiments suggest a tendency for internal variability to decrease along the course of the century, a new result that will benefit from further analysis over a larger set of models. Benefits of mitigation, all else being equal in terms of societal drivers, appear clearly when comparing scenarios developed under the same SSP, but to which different degrees of mitigation have been applied. It is also found that a mild overshoot in temperature of a few decades in mid-century, as represented in SSP5-3.4OS, does not affect the end outcome in terms of temperature and precipitation changes by 2100, which return to the same level as those reached by the gradually increasing SSP4-3.4. Central estimates of the time at which the ensemble means of the different scenarios reach a given warming level show all scenarios reaching 1.5 °C of warming compared to the 1850–1900 baseline in the second half of the current decade, with the time span between slow and fast warming covering 20–28 years from present. 2 °C of warming is reached as early as the late '30s by the ensemble mean under SSP5-8.5, but as late as the late '50s under SSP1-2.6. The highest warming level considered, 5 °C, is reached only by the ensemble mean under SSP5-8.5, and not until the mid-90s.

Journal ArticleDOI
Sebastian Günther, P. Reinke, Yaiza Fernández-García1, J. Lieske, Thomas J. Lane, Helen M. Ginn, Faisal Hammad Mekky Koua, Christiane Ehrt2, W. Ewert, Dominik Oberthuer, Oleksandr Yefanov, S. Meier2, Kristina Lorenzen3, Boris Krichel4, Janine-Denise Kopicki4, Luca Gelisio, W. Brehm, Ilona Dunkel5, B. Seychell2, Henry Gieseler2, Brenna Norton-Baker5, Brenna Norton-Baker6, Beatriz Escudero-Pérez1, M. Domaracky, S. Saouane, A. Tolstikova, Thomas A. White, Anna Hänle, M. Groessler, Holger Fleckenstein, F. Trost, M. Galchenkova, Y. Gevorkov7, Chufeng Li, Salah Awel, Ariana Peck8, Miriam Barthelmess, Frank Schlünzen, P. Lourdu Xavier5, N. Werner2, H. Andaleeb2, N. Ullah2, Sven Falke2, Vasundara Srinivasan2, Bruno Alves Franca2, M. Schwinzer2, Hévila Brognaro2, Cromarte Rogers2, D. Melo2, Joanna J. Zaitseva-Doyle2, Juraj Knoska, Gisel E. Peña-Murillo, Aida Rahmani Mashhour, V. Hennicke, Pontus Fischer, Johanna Hakanpää, Jan Meyer, Philip Gribbon9, Bernhard Ellinger9, Maria Kuzikov9, Markus Wolf9, Andrea R. Beccari, Gleb Bourenkov10, David von Stetten10, Guillaume Pompidor10, Isabel Bento10, Saravanan Panneerselvam10, Ivars Karpics10, Thomas R. Schneider10, Maria Garcia-Alai10, Stephan Niebling10, Christian M. Günther10, C. Schmidt3, Robin Schubert3, Huijong Han3, J. Boger11, Diana C. F. Monteiro12, Linlin Zhang11, Xinyuanyuan Sun11, J. Pletzer-Zelgert2, J. Wollenhaupt13, Christian G. Feiler13, Manfred S. Weiss13, Eike C. Schulz5, Pedram Mehrabi5, Katarina Karničar14, Aleksandra Usenik14, Jure Loboda14, Henning Tidow2, Ashwin Chari5, Rolf Hilgenfeld11, Charlotte Uetrecht4, Russell J. Cox15, Andrea Zaliani9, Tobias Beck2, Matthias Rarey2, Stephan Günther1, Dušan Turk14, Winfried Hinrichs2, Winfried Hinrichs16, Henry N. Chapman2, Arwen R. Pearson2, Christian Betzel2, Alke Meents 
07 May 2021-Science
TL;DR: In this article, a high-throughput x-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (Mpro), which is essential for viral replication, was performed.
Abstract: The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput x-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (Mpro), which is essential for viral replication. In contrast to commonly applied x-ray fragment screening experiments with molecules of low complexity, our screen tested already-approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to Mpro In subsequent cell-based viral reduction assays, one peptidomimetic and six nonpeptidic compounds showed antiviral activity at nontoxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2.


Journal ArticleDOI
B. P. Abbott1, Richard J. Abbott1, T. D. Abbott2, Sheelu Abraham3  +1273 moreInstitutions (140)
TL;DR: In this article, the first and second observing runs of the Advanced LIGO and Virgo detector network were used to obtain the first standard-siren measurement of the Hubble constant (H 0).
Abstract: This paper presents the gravitational-wave measurement of the Hubble constant (H 0) using the detections from the first and second observing runs of the Advanced LIGO and Virgo detector network. The presence of the transient electromagnetic counterpart of the binary neutron star GW170817 led to the first standard-siren measurement of H 0. Here we additionally use binary black hole detections in conjunction with galaxy catalogs and report a joint measurement. Our updated measurement is H 0 = km s−1 Mpc−1 (68.3% of the highest density posterior interval with a flat-in-log prior) which is an improvement by a factor of 1.04 (about 4%) over the GW170817-only value of km s−1 Mpc−1. A significant additional contribution currently comes from GW170814, a loud and well-localized detection from a part of the sky thoroughly covered by the Dark Energy Survey. With numerous detections anticipated over the upcoming years, an exhaustive understanding of other systematic effects are also going to become increasingly important. These results establish the path to cosmology using gravitational-wave observations with and without transient electromagnetic counterparts.

Journal ArticleDOI
03 Jun 2021-Nature
TL;DR: In this paper, the authors analyzed a combined total of 45,148 dissolved oxygen and temperature profiles and calculate trends for 393 temperate lakes that span 1941 to 2017, finding that a decline in dissolved oxygen is widespread in surface and deep water habitats.
Abstract: The concentration of dissolved oxygen in aquatic systems helps to regulate biodiversity1,2, nutrient biogeochemistry3, greenhouse gas emissions4, and the quality of drinking water5. The long-term declines in dissolved oxygen concentrations in coastal and ocean waters have been linked to climate warming and human activity6,7, but little is known about the changes in dissolved oxygen concentrations in lakes. Although the solubility of dissolved oxygen decreases with increasing water temperatures, long-term lake trajectories are difficult to predict. Oxygen losses in warming lakes may be amplified by enhanced decomposition and stronger thermal stratification8,9 or oxygen may increase as a result of enhanced primary production10. Here we analyse a combined total of 45,148 dissolved oxygen and temperature profiles and calculate trends for 393 temperate lakes that span 1941 to 2017. We find that a decline in dissolved oxygen is widespread in surface and deep-water habitats. The decline in surface waters is primarily associated with reduced solubility under warmer water temperatures, although dissolved oxygen in surface waters increased in a subset of highly productive warming lakes, probably owing to increasing production of phytoplankton. By contrast, the decline in deep waters is associated with stronger thermal stratification and loss of water clarity, but not with changes in gas solubility. Our results suggest that climate change and declining water clarity have altered the physical and chemical environment of lakes. Declines in dissolved oxygen in freshwater are 2.75 to 9.3 times greater than observed in the world’s oceans6,7 and could threaten essential lake ecosystem services2,3,5,11. Analysis of temperate lakes finds a widespread decline in dissolved oxygen concentrations in surface and deep waters, which is associated with reduced solubility at warmer surface water temperatures and increased stratification at depth.

Journal ArticleDOI
Christian Koelsche1, Christian Koelsche2, Daniel Schrimpf2, Daniel Schrimpf1, Damian Stichel1, Martin Sill1, Felix Sahm1, Felix Sahm2, David E. Reuss1, David E. Reuss2, Mirjam Blattner1, Barbara C. Worst2, Barbara C. Worst1, Christoph E. Heilig1, Katja Beck1, Peter Horak1, Simon Kreutzfeldt1, Elke Paff2, Elke Paff1, Sebastian Stark2, Sebastian Stark1, Pascal Johann1, Pascal Johann2, Florian Selt1, Florian Selt2, Jonas Ecker1, Jonas Ecker2, Dominik Sturm2, Dominik Sturm1, Kristian W. Pajtler1, Kristian W. Pajtler2, Annekathrin Reinhardt2, Annekathrin Reinhardt1, Annika K. Wefers2, Annika K. Wefers1, Philipp Sievers2, Philipp Sievers1, Azadeh Ebrahimi1, Abigail K. Suwala1, Abigail K. Suwala2, Francisco Fernández-Klett1, Francisco Fernández-Klett2, Belen Casalini1, Andrey Korshunov2, Andrey Korshunov1, Volker Hovestadt3, Volker Hovestadt4, Felix K. F. Kommoss2, Mark Kriegsmann2, Matthias Schick1, Melanie Bewerunge-Hudler1, Till Milde1, Till Milde2, Olaf Witt2, Olaf Witt1, Andreas E. Kulozik2, Marcel Kool1, Laura Romero-Pérez5, Thomas G. P. Grunewald5, Thomas Kirchner5, Wolfgang Wick1, Wolfgang Wick2, Michael Platten6, Michael Platten1, Andreas Unterberg2, Matthias Uhl2, Amir Abdollahi, Jürgen Debus, Burkhard Lehner2, Christian Thomas7, Martin Hasselblatt7, Werner Paulus7, Christian Hartmann8, Ori Staszewski9, Marco Prinz9, Jürgen Hench10, Stephan Frank10, Yvonne M.H. Versleijen-Jonkers11, Marije E. Weidema11, Thomas Mentzel, Klaus G. Griewank12, Enrique de Álava13, Juan Díaz Martín13, Miguel Angel Idoate Gastearena14, Kenneth Tou En Chang15, Sharon Yin Yee Low, Adrian Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek16, Stefan Rutkowski16, Ulrich Schüller16, V. F. Mautner16, Jens Schittenhelm, Jonathan Serrano17, Matija Snuderl17, Reinhard Büttner18, Thomas Klingebiel15, Rolf Buslei, Manfred Gessler, Pieter Wesseling19, Winand N.M. Dinjens20, Sebastian Brandner21, Sebastian Brandner22, Zane Jaunmuktane21, Zane Jaunmuktane23, Iben Lyskjaer22, Peter Schirmacher2, Albrecht Stenzinger2, Benedikt Brors1, Hanno Glimm, Christoph Heining1, Christoph Heining24, Oscar M. Tirado, Miguel Sáinz-Jaspeado, Jaume Mora25, Javier Alonso26, Xavier Garcia del Muro27, Sebastian Moran, Manel Esteller, Jamal Benhamida28, Marc Ladanyi28, Eva Wardelmann7, Cristina R. Antonescu28, Adrienne M. Flanagan29, Adrienne M. Flanagan22, Uta Dirksen12, Peter Hohenberger6, Daniel Baumhoer10, Wolfgang Hartmann7, Christian Vokuhl, Uta Flucke11, Iver Petersen, Gunhild Mechtersheimer2, David Capper30, David T.W. Jones1, Stefan Fröhling1, Stefan M. Pfister1, Stefan M. Pfister2, Andreas von Deimling2, Andreas von Deimling1 
TL;DR: In this paper, a machine learning classifier algorithm based on array-generated DNA methylation data was used for the classification of soft tissue and bone sarcoma. But the performance was validated in a cohort of 428 sarcomatous tumours, of which 322 cases were classified by the classifier.
Abstract: Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents and children. They represent a morphologically heterogeneous class of tumours and some entities lack defining histopathological features. Therefore, the diagnosis of sarcomas is burdened with a high inter-observer variability and misclassification rate. Here, we demonstrate classification of soft tissue and bone tumours using a machine learning classifier algorithm based on array-generated DNA methylation data. This sarcoma classifier is trained using a dataset of 1077 methylation profiles from comprehensively pre-characterized cases comprising 62 tumour methylation classes constituting a broad range of soft tissue and bone sarcoma subtypes across the entire age spectrum. The performance is validated in a cohort of 428 sarcomatous tumours, of which 322 cases were classified by the sarcoma classifier. Our results demonstrate the potential of the DNA methylation-based sarcoma classification for research and future diagnostic applications.

Journal ArticleDOI
Jens H. Kuhn1, Scott Adkins2, Daniela Alioto3, S. V. Alkhovsky4  +231 moreInstitutions (125)
TL;DR: The updated taxonomy of Negarnaviricota is presented, as now accepted by the ICTV, after the phylum was amended and emended in March 2020.
Abstract: In March 2020, following the annual International Committee on Taxonomy of Viruses (ICTV) ratification vote on newly proposed taxa, the phylum Negarnaviricota was amended and emended. At the genus rank, 20 new genera were added, two were deleted, one was moved, and three were renamed. At the species rank, 160 species were added, four were deleted, ten were moved and renamed, and 30 species were renamed. This article presents the updated taxonomy of Negarnaviricota as now accepted by the ICTV.

Journal ArticleDOI
Cathrine Axfors1, Cathrine Axfors2, Andreas M. Schmitt3, Andreas M. Schmitt4, Perrine Janiaud4, Janneke van’t Hooft1, Janneke van’t Hooft5, Sherief Abd-Elsalam6, Ehab F. Abdo7, Benjamin S. Abella8, Javed Akram9, Ravi K. Amaravadi8, Derek C. Angus10, Yaseen M. Arabi11, Shehnoor Azhar9, Lindsey R. Baden12, Arthur W. Baker13, Leila Belkhir14, Thomas Benfield15, Marvin A.H. Berrevoets, Cheng-Pin Chen16, Tsung-Chia Chen16, Shu-Hsing Cheng16, Chien-Yu Cheng16, Wei-Sheng Chung16, Yehuda Z. Cohen, Lisa N. Cowan, Olav Dalgard17, Olav Dalgard18, Fernando Val, Marcus V. G. Lacerda19, Gisely Cardoso de Melo, Lennie P. G. Derde20, Vincent Dubée, Anissa Elfakir, Anthony C. Gordon21, Carmen M. Hernández-Cárdenas, Thomas Hills22, Thomas Hills23, Andy I. M. Hoepelman20, Yi-Wen Huang16, Bruno Igau, Ronghua Jin24, Felipe Jurado-Camacho, Khalid S. Khan25, Peter G. Kremsner26, Benno Kreuels27, Benno Kreuels28, Cheng-Yu Kuo16, Thuy Le13, Yi-Chun Lin16, Wu-Pu Lin16, Tse-Hung Lin16, Magnus Nakrem Lyngbakken17, Magnus Nakrem Lyngbakken18, Colin McArthur23, Colin McArthur22, Colin McArthur29, Bryan J. McVerry10, Patricia Meza-Meneses, Wuelton Marcelo Monteiro, Susan C. Morpeth30, Ahmad Mourad13, Mark J. Mulligan, Srinivas Murthy31, Susanna Naggie13, Shanti Narayanasamy13, Alistair Nichol, Lewis A. Novack12, Sean M. O'Brien13, Nwora Lance Okeke13, Léna Perez, Rogelio Perez-Padilla, Laurent Perrin, Arantxa Remigio-Luna, Norma E. Rivera-Martinez, Frank W. Rockhold13, Sebastian Rodriguez-Llamazares, Robert Rolfe13, Rossana Rosa32, Helge Røsjø17, Helge Røsjø18, Vanderson de Souza Sampaio, Todd B. Seto33, Todd B. Seto34, Muhammad Shahzad9, Shaimaa Soliman35, Jason E. Stout13, Ireri Thirion-Romero, Andrea B. Troxel, Ting-Yu Tseng16, Nicholas A Turner13, Robert J. Ulrich, Stephen R. Walsh12, Steve Webb29, Steve Webb36, Jesper M. Weehuizen20, Maria Velinova, Hon-Lai Wong16, Rebekah Wrenn13, Fernando G. Zampieri, Wu Zhong, David Moher37, Steven N. Goodman1, John P. A. Ioannidis, Lars G. Hemkens1, Lars G. Hemkens4 
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.
Abstract: Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine and chloroquine on survival in COVID-19 from all currently available RCT evidence, published and unpublished. We present a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients (protocol: https://osf.io/QESV4/ ). We systematically identified unpublished RCTs (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, Cochrane COVID-registry up to June 11, 2020), and published RCTs (PubMed, medRxiv and bioRxiv up to October 16, 2020). All-cause mortality has been extracted (publications/preprints) or requested from investigators and combined in random-effects meta-analyses, calculating odds ratios (ORs) with 95% confidence intervals (CIs), separately for hydroxychloroquine and chloroquine. Prespecified subgroup analyses include patient setting, diagnostic confirmation, control type, and publication status. Sixty-three trials were potentially eligible. We included 14 unpublished trials (1308 patients) and 14 publications/preprints (9011 patients). Results for hydroxychloroquine are dominated by RECOVERY and WHO SOLIDARITY, two highly pragmatic trials, which employed relatively high doses and included 4716 and 1853 patients, respectively (67% of the total sample size). The combined OR on all-cause mortality for hydroxychloroquine is 1.11 (95% CI: 1.02, 1.20; I² = 0%; 26 trials; 10,012 patients) and for chloroquine 1.77 (95%CI: 0.15, 21.13, I² = 0%; 4 trials; 307 patients). We identified no subgroup effects. We found that treatment with hydroxychloroquine is associated with increased mortality in COVID-19 patients, and there is no benefit of chloroquine. Findings have unclear generalizability to outpatients, children, pregnant women, and people with comorbidities. Hydroxychloroquine and chloroquine have been investigated as a potential treatment for Covid-19 in several clinical trials. Here the authors report a meta-analysis of published and unpublished trials, and show that treatment with hydroxychloroquine for patients with Covid-19 was associated with increased mortality, and there was no benefit from chloroquine.

Journal ArticleDOI
TL;DR: HiggsSignals as discussed by the authors is a program that combines the predictions of models with arbitrary Higgs sectors with the available Higgs signal rate and mass measurements, resulting in a likelihood estimate.
Abstract: The program HiggsSignals confronts the predictions of models with arbitrary Higgs sectors with the available Higgs signal rate and mass measurements, resulting in a likelihood estimate. A new version of the program, HiggsSignals-2, is presented that contains various improvements in its functionality and applicability. In particular, the new features comprise improvements in the theoretical input framework and the handling of possible complexities of beyond-the-SM Higgs sectors, as well as the incorporation of experimental results in the form of simplified template cross section (STXS) measurements. The new functionalities are explained, and a thorough discussion of the possible statistical interpretations of the HiggsSignals results is provided. The performance of HiggsSignals is illustrated for some example analyses. In this context the importance of public information on certain experimental details like efficiencies and uncertainty correlations is pointed out. HiggsSignals is continuously updated to the latest experimental results and can be obtained at https://gitlab.com/higgsbounds/higgssignals.

Journal ArticleDOI
24 Mar 2021-Nature
TL;DR: In this paper, a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), was used to detect the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics.
Abstract: Nonalcoholic steatohepatitis (NASH) is a manifestation of systemic metabolic disease related to obesity, and causes liver disease and cancer1,2. The accumulation of metabolites leads to cell stress and inflammation in the liver3, but mechanistic understandings of liver damage in NASH are incomplete. Here, using a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), we found an indispensable role for T cells in liver immunopathology. We detected the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics. Liver CXCR6+ CD8 T cells were characterized by low activity of the FOXO1 transcription factor, and were abundant in NASH mice and in patients with NASH. Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation, which together rendered liver-resident CXCR6+ CD8 T cells susceptible to metabolic stimuli (including acetate and extracellular ATP) and collectively triggered auto-aggression. CXCR6+ CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors. This killing by auto-aggressive CD8 T cells fundamentally differed from that by antigen-specific cells, which mechanistically distinguishes auto-aggressive and protective T cell immunity.


Journal ArticleDOI
TL;DR: A major aim of this guide is to help break down barriers between the many subdisciplines of root ecology and ecophysiology, broaden researchers’ views on the multiple aspects of root study and create favourable conditions for the inception of comprehensive experiments on the role of roots in plant and ecosystem functioning.
Abstract: In the context of a recent massive increase in research on plant root functions and their impact on the environment, root ecologists currently face many important challenges to keep on generating cutting-edge, meaningful and integrated knowledge. Consideration of the below-ground components in plant and ecosystem studies has been consistently called for in recent decades, but methodology is disparate and sometimes inappropriate. This handbook, based on the collective effort of a large team of experts, will improve trait comparisons across studies and integration of information across databases by providing standardised methods and controlled vocabularies. It is meant to be used not only as starting point by students and scientists who desire working on below-ground ecosystems, but also by experts for consolidating and broadening their views on multiple aspects of root ecology. Beyond the classical compilation of measurement protocols, we have synthesised recommendations from the literature to provide key background knowledge useful for: (1) defining below-ground plant entities and giving keys for their meaningful dissection, classification and naming beyond the classical fine-root vs coarse-root approach; (2) considering the specificity of root research to produce sound laboratory and field data; (3) describing typical, but overlooked steps for studying roots (e.g. root handling, cleaning and storage); and (4) gathering metadata necessary for the interpretation of results and their reuse. Most importantly, all root traits have been introduced with some degree of ecological context that will be a foundation for understanding their ecological meaning, their typical use and uncertainties, and some methodological and conceptual perspectives for future research. Considering all of this, we urge readers not to solely extract protocol recommendations for trait measurements from this work, but to take a moment to read and reflect on the extensive information contained in this broader guide to root ecology, including sections I-VII and the many introductions to each section and root trait description. Finally, it is critical to understand that a major aim of this guide is to help break down barriers between the many subdisciplines of root ecology and ecophysiology, broaden researchers' views on the multiple aspects of root study and create favourable conditions for the inception of comprehensive experiments on the role of roots in plant and ecosystem functioning.

Journal ArticleDOI
13 Jul 2021-Immunity
TL;DR: In this paper, the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients.